drug · antibody
patient view →belimumab
Phase 3updated 2mo agoby $GSK GSK plc🔗 ChEMBL
Phase 3community read0 votes
Antibody drug with a maximum clinical stage of Approval (across all indications), with an approval for lupus nephritis and systemic lupus erythematosus and 17 investigational indications.
indications
indications
Lupus
targets
Tumor necrosis factor ligand superfamily member 13B
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that